-
Reproductive rights in the United States: acquiescence is not a strategy Nat. Med. (IF 82.9) Pub Date : 2024-04-25 Laura J. Esserman, Douglas Yee
Scientific and medical conferences should not be held in states that ban abortion, as such bans put the lives of women at risk.
-
Large language models for preventing medication direction errors in online pharmacies Nat. Med. (IF 82.9) Pub Date : 2024-04-25 Cristobal Pais, Jianfeng Liu, Robert Voigt, Vin Gupta, Elizabeth Wade, Mohsen Bayati
-
Urgent action is needed to confront artemisinin partial resistance in African malaria parasites Nat. Med. (IF 82.9) Pub Date : 2024-04-25
Discover the world’s best science and medicine | Nature.com
-
Druglike, 18F-labeled PET Tracers Targeting Fibroblast Activation Protein J. Med. Chem. (IF 7.3) Pub Date : 2024-04-24 Muhammet Tanc, Nicolò Filippi, Yentl Van Rymenant, Sergei Grintsevich, Isabel Pintelon, Marlies Verschuuren, Joni De Loose, Emile Verhulst, Euy Sung Moon, Lorenzo Cianni, Sigrid Stroobants, Koen Augustyns, Frank Roesch, Ingrid De Meester, Filipe Elvas, Pieter Van der Veken
-
Discovery of a Novel Orally Bioavailable FLT3-PROTAC Degrader for Efficient Treatment of Acute Myeloid Leukemia and Overcoming Resistance of FLT3 Inhibitors J. Med. Chem. (IF 7.3) Pub Date : 2024-04-24 Junwei Wang, Quanjin Rong, Lei Ye, Bingqian Fang, Yifan Zhao, Yu Sun, Haikun Zhou, Dan Wang, Jinting He, Zhenzhen Cui, Qijian Zhang, Di Kang, Lihong Hu
-
Discovery of Novel Dual Inhibitors Targeting Mutant IDH1 and NAMPT for the Treatment of Glioma with IDH1Mutation J. Med. Chem. (IF 7.3) Pub Date : 2024-04-23 Fei Wen, Gang Gui, Xiaoyu Wang, Anqi Qin, Tianfang Ma, Hui Chen, Chunzheng Li, Xiaoming Zha
-
Development of Prolinol Containing Inhibitors of Hypoxanthine–Guanine–Xanthine Phosphoribosyltransferase: Rational Structure-Based Drug Design J. Med. Chem. (IF 7.3) Pub Date : 2024-04-23 Dianne T. Keough, Magdalena Petrová, Gordon King, Michal Kratochvíl, Radek Pohl, Eva Doleželová, Alena Zíková, Luke W. Guddat, Dominik Rejman
-
Virtual Screening Strategies for Identifying Novel Chemotypes J. Med. Chem. (IF 7.3) Pub Date : 2024-04-23 Stuart Lang, Martin J. Slater
The identification of active compounds, or a series of compounds, is the crucial first step in all drug discovery projects. Ideally these compounds should display, or have the potential to display after optimization, good physical chemistry, and drug like properties. Screening, both physical and virtual, is a process that involves interrogating a protein target of interest with large numbers of compounds
-
Discovery of Highly Potent and Efficient CBP/p300 Degraders with Strong In Vivo Antitumor Activity J. Med. Chem. (IF 7.3) Pub Date : 2024-04-22 Jiankang Hu, Hongrui Xu, Tianbang Wu, Cheng Zhang, Hui Shen, Ruibo Dong, Qingqing Hu, Qiuping Xiang, Shuang Chai, Guolong Luo, Xiaoshan Chen, Yumin Huang, Xiaofan Zhao, Chao Peng, Xishan Wu, Bin Lin, Yan Zhang, Yong Xu
-
Discovery and Structure–Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT2A Receptor Agonists J. Med. Chem. (IF 7.3) Pub Date : 2024-04-22 Emil M. Ro̷rsted, Anders A. Jensen, Gints Smits, Karla Frydenvang, Jesper L. Kristensen
-
Design of Evodiamine–Glucose Conjugates with Improved In Vivo Antitumor Activity J. Med. Chem. (IF 7.3) Pub Date : 2024-04-22 Zhe Wu, Shuqiang Chen, Zhipeng Chen, Guoqiang Dong, Defeng Xu, Chunquan Sheng
-
Discovery and Mechanistic Studies of Dual-Target Hits for Carbonic Anhydrase IX and VEGFR-2 as Potential Agents for Solid Tumors: X-ray, In Vitro, In Vivo, and In Silico Investigations of Coumarin-Based Thiazoles J. Med. Chem. (IF 7.3) Pub Date : 2024-04-20 Salma M. Hefny, Tarek F. El-Moselhy, Nabaweya El-Din, Simone Giovannuzzi, Thamer Bin Traiki, Mansoor-Ali Vaali-Mohammed, Ahmed M. El-Dessouki, Koki Yamaguchi, Masaharu Sugiura, Moataz A. Shaldam, Claudiu T. Supuran, Maha-Hamadien Abdulla, Wagdy M. Eldehna, Haytham O. Tawfik
-
Lead Optimization of Butyrolactone I as an Orally Bioavailable Antiallergic Agent Targeting FcγRIIB J. Med. Chem. (IF 7.3) Pub Date : 2024-04-19 Chun-Lan Xie, Hong-Xiu Xiao, Pei-Fang Song, Qing-Mei Liu, Haoxiang Wei, Liang Wu, Guang-Hao Zhu, Guang-Ming Liu, Yandong Zhang, Ping Wang, Xian-Wen Yang
-
FETPY: a Diiron(I) Thio–Carbyne Complex with Prominent Anticancer Activity In Vitro and In Vivo J. Med. Chem. (IF 7.3) Pub Date : 2024-04-19 Ekatarina Mihajlović, Lorenzo Biancalana, Sanja Jelača, Lorenzo Chiaverini, Biljana Dojčinović, Duško Dunđerović, Stefano Zacchini, Sanja Mijatović, Danijela Maksimović-Ivanić, Fabio Marchetti
-
RIPK3 inhibitor prevents lung damage in severe influenza infection Nat. Rev. Drug. Disc. (IF 120.1) Pub Date : 2024-04-24
Discover the world’s best science and medicine | Nature.com
-
mRNA therapy shows promise for metabolic disorder Nat. Rev. Drug. Disc. (IF 120.1) Pub Date : 2024-04-23
Discover the world’s best science and medicine | Nature.com
-
New risk score for cardiovascular disease with improved performance Nat. Med. (IF 82.9) Pub Date : 2024-04-23
-
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses Nat. Med. (IF 82.9) Pub Date : 2024-04-23 Claire F. Friedman, Beryl L. Manning-Geist, Qin Zhou, Tara Soumerai, Aliya Holland, Arnaud Da Cruz Paula, Hunter Green, Melih Arda Ozsoy, Alexia Iasonos, Travis Hollmann, Mario M. Leitao, Jennifer J. Mueller, Vicky Makker, William P. Tew, Roisin E. O’Cearbhaill, Ying L. Liu, Maria M. Rubinstein, Tiffany Troso-Sandoval, Stuart M. Lichtman, Alison Schram, Chrisann Kyi, Rachel N. Grisham, Pamela Causa
-
Discovery of novel ocotillol derivatives modulating glucocorticoid receptor/NF-κB signaling for the treatment of sepsis Eur. J. Med. Chem. (IF 6.7) Pub Date : 2024-04-23 Gongshan Ma, Xiaojin Gao, Xin Zhang, Haixia Li, Zhiyuan Geng, Jing Gao, Shuxin Yang, Zhiruo Sun, Yuqi Lin, Xiaomei Wen, Qingguo Meng, Leiming Zhang, Yi Bi
-
The hype and hope of new food allergy treatments Nat. Med. (IF 82.9) Pub Date : 2024-04-22 Kirsten P. Perrett
-
Strategies for controlling pneumococcal disease and outbreaks during humanitarian emergencies Nat. Med. (IF 82.9) Pub Date : 2024-04-22 Molly Cliff, Paul Welaga, Nuredin Mohammed, Patrick Ansah, Robert S. Heyderman, Caroline Trotter, Brenda Kwambana-Adams
Streptococcus pneumoniae infection accounts for nearly one-fifth of all meningitis deaths globally, half of which occur in Sub-Saharan Africa. Pneumococcal conjugate vaccines (PCVs) prevent vaccine-serotype disease and have been rolled out as part of infant immunization programs worldwide1. Despite widespread PCV usage, the burden of pneumococcal meningitis remains highest within the so called ‘African
-
mRNA therapy for a rare childhood disease Nat. Med. (IF 82.9) Pub Date : 2024-04-22
An mRNA-based drug aims to replace a faulty enzyme and restore metabolic function in children with propionic acidemia — with encouraging early clinical results.
-
Repurposing a diabetes drug to treat Parkinson’s disease Nat. Med. (IF 82.9) Pub Date : 2024-04-20
In a multicenter clinical trial, patients with early-stage Parkinson’s disease treated with lixisenatide, a drug currently used for the treatment of diabetes, showed improvement in their motor scores compared with those on placebo.
-
Using unlabeled data to enhance fairness of medical AI Nat. Med. (IF 82.9) Pub Date : 2024-04-19 Rajiv Movva, Pang Wei Koh, Emma Pierson
AI models for tasks such as pathology and dermatology struggle to generalize to new patient groups or hospitals that they were not trained on; learning more robust features from unlabeled data could prevent overfitting to the training distribution and thereby increase fairness.
-
Microplastics are everywhere — we need to understand how they affect human health Nat. Med. (IF 82.9) Pub Date : 2024-04-19
As evidence emerges describing the accumulation of small plastic particles in various organs and tissues of the body, a much deeper understanding of the effects of these particles on human health is urgently needed.
-
Demographic bias in misdiagnosis by computational pathology models Nat. Med. (IF 82.9) Pub Date : 2024-04-19 Anurag Vaidya, Richard J. Chen, Drew F. K. Williamson, Andrew H. Song, Guillaume Jaume, Yuzhe Yang, Thomas Hartvigsen, Emma C. Dyer, Ming Y. Lu, Jana Lipkova, Muhammad Shaban, Tiffany Y. Chen, Faisal Mahmood
-
Risk-based lung cancer screening performance in a universal healthcare setting Nat. Med. (IF 82.9) Pub Date : 2024-04-19 Martin C. Tammemägi, Gail E. Darling, Heidi Schmidt, Meghan J. Walker, Deanna Langer, Yvonne W. Leung, Kathy Nguyen, Beth Miller, Diego Llovet, William K. Evans, Daniel N. Buchanan, Gabriela Espino-Hernandez, Usman Aslam, Amanda Sheppard, Aisha Lofters, Micheal McInnis, Julian Dobranowski, Steven Habbous, Christian Finley, Marianne Luettschwager, Erin Cameron, Caroline Bravo, Anna Banaszewska, Katherin
-
Research strategies of small molecules as chemotherapeutics to overcome multiple myeloma resistance Eur. J. Med. Chem. (IF 6.7) Pub Date : 2024-04-20 Jin Yang, Yan-Cheng Yu, Zi-Xuan Wang, Qing-Qing Li, Ning Ding, Xue-Jiao Leng, Jiao Cai, Meng-Yuan Zhang, Jing-Jing Wang, Yun Zhou, Tian-Hua Wei, Xin Xue, Wei-Chen Dai, Shan-Liang Sun, Ye Yang, Nian-Guang Li, Zhi-Hao Shi
-
Probing benzenesulfonamide–thiazolidinone hybrids as multitarget directed ligands for efficient control of type 2 diabetes mellitus through targeting the enzymes: α-glucosidase and carbonic anhydrase II Eur. J. Med. Chem. (IF 6.7) Pub Date : 2024-04-20 Mona A. Gamal, Samar H. Fahim, Simone Giovannuzzi, Marwa A. Fouad, Alessandro Bonardi, Paola Gratteri, Claudiu T. Supuran, Ghaneya S. Hassan
-
Identification of naphthalimide-derivatives as novel PBD-targeted polo-like kinase 1 inhibitors with efficacy in drug-resistant lung cancer cells Eur. J. Med. Chem. (IF 6.7) Pub Date : 2024-04-20 Pingping Li, Yongkun Li, Xuesong Ma, Liangping Li, Shulan Zeng, Yan Peng, Hong Liang, Guohai Zhang
-
Climate change and health: understanding mechanisms will inform mitigation and prevention strategies Nat. Med. (IF 82.9) Pub Date : 2024-04-19 Diddier Prada, Andrea A. Baccarelli, Allison Kupsco, Robbie M. Parks
-
Post-election responsibilities for public health in the Democratic Republic of the Congo Nat. Med. (IF 82.9) Pub Date : 2024-04-19 Faraan O. Rahim, William C. Lieber, Julian T. Hertz, Bruce Shinga Wembulua, Patrick A. Ndeba, Richard M. Lukelwa
Since gaining independence in 1960, the Democratic Republic of the Congo (DRC) has faced a complicated series of challenges marked by armed conflict, political instability and economic hardships. Tensions in the DRC are on an escalating trajectory as the Congolese army and its allied militias battle with the March 23 Movement group in North and South Kivu. Attempts to restore peace through the Nairobi
-
Opportunities and challenges following approval of resmetirom for MASH liver disease Nat. Med. (IF 82.9) Pub Date : 2024-04-19 Jeffrey V. Lazarus, Dana Ivancovsky Wajcman, Henry E. Mark, Zobair M. Younossi, Christopher J. Kopka, Nevin Cohen, Meena B. Bansal, Michael Betel, Paul N. Brennan
-
An autoantibody signature predictive for multiple sclerosis Nat. Med. (IF 82.9) Pub Date : 2024-04-19 Colin R. Zamecnik, Gavin M. Sowa, Ahmed Abdelhak, Ravi Dandekar, Rebecca D. Bair, Kristen J. Wade, Christopher M. Bartley, Kerry Kizer, Danillo G. Augusto, Asritha Tubati, Refujia Gomez, Camille Fouassier, Chloe Gerungan, Colette M. Caspar, Jessica Alexander, Anne E. Wapniarski, Rita P. Loudermilk, Erica L. Eggers, Kelsey C. Zorn, Kirtana Ananth, Nora Jabassini, Sabrina A. Mann, Nicholas R. Ragan,
-
Causal machine learning for predicting treatment outcomes Nat. Med. (IF 82.9) Pub Date : 2024-04-19 Stefan Feuerriegel, Dennis Frauen, Valentyn Melnychuk, Jonas Schweisthal, Konstantin Hess, Alicia Curth, Stefan Bauer, Niki Kilbertus, Isaac S. Kohane, Mihaela van der Schaar
-
Brain-Permeable Immunoproteasome-Targeting Macrocyclic Peptide Epoxyketones for Alzheimer’s Disease J. Med. Chem. (IF 7.3) Pub Date : 2024-04-18 Ji Eun Park, Chhabi L. Chaudhary, Deepak Bhattarai, Kyung Bo Kim
-
Unexpected Noncovalent Off-Target Activity of Clinical BTK Inhibitors Leads to Discovery of a Dual NUDT5/14 Antagonist J. Med. Chem. (IF 7.3) Pub Date : 2024-04-18 Esra Balıkçı, Anne-Sophie M. C. Marques, Ludwig G. Bauer, Raina Seupel, James Bennett, Brigitt Raux, Karly Buchan, Klemensas Simelis, Usha Singh, Catherine Rogers, Jennifer Ward, Carol Cheng, Tamas Szommer, Kira Schützenhofer, Jonathan M. Elkins, David L. Sloman, Ivan Ahel, Oleg Fedorov, Paul E. Brennan, Kilian V. M. Huber
-
Selective Elimination of Senescent Cancer Cells by Galacto-Modified PROTACs J. Med. Chem. (IF 7.3) Pub Date : 2024-04-18 Mengyang Chang, Feng Gao, Giri Gnawali, Hang Xu, Yue Dong, Xiang Meng, Wenpan Li, Zhiren Wang, Byrdie Lopez, Jennifer S. Carew, Steffan T. Nawrocki, Jianqin Lu, Qing-Yu Zhang, Wei Wang
-
Gemfibrozil-Platinum(IV) Precursors for New Enhanced-Starvation and Chemotherapy In Vitro and In Vivo J. Med. Chem. (IF 7.3) Pub Date : 2024-04-18 Xue-Qing Song, Xu Guo, Yi-Xin Ding, Yi-Xuan Han, Zhi-Hao You, Yali Song, Yanan Yuan, Longfei Li
-
Monophosphoryl Lipid A-Rhamnose Conjugates as a New Class of Vaccine Adjuvants J. Med. Chem. (IF 7.3) Pub Date : 2024-04-18 Rajendra Rohokale, Jiatong Guo, Zhongwu Guo
-
Arene–Arene Coupled Disulfamethazines (or Sulfadiazine)-Phenanthroline-Metal(II) Complexes were Synthesized by In Situ Reactions and Inhibited the Growth and Development of Triple-Negative Breast Cancer through the Synergistic Effect of Antiangiogenesis, Anti-Inflammation, Pro-Apoptosis, and Cuproptosis J. Med. Chem. (IF 7.3) Pub Date : 2024-04-18 Bing-Bing Xu, Nan Jin, Ji-Cheng Liu, Ai-Qiu Liao, Hong-Yu Lin, Xiu-Ying Qin
-
Discovery of a Meisoindigo-Derived PROTAC as the ATM Degrader: Revolutionizing Colorectal Cancer Therapy via Synthetic Lethality with ATR Inhibitors J. Med. Chem. (IF 7.3) Pub Date : 2024-04-18 Ting-Ting Liu, Qing Wang, Yuxing Zhou, Baixin Ye, Tingting Liu, Linyang Yan, Jinbao Fan, Jiahao Xu, Yingjun Zhou, Zanxian Xia, Xu Deng
-
RNA-editing drugs advance into clinical trials Nat. Rev. Drug. Disc. (IF 120.1) Pub Date : 2024-04-18
ADAR-based editors that can change the mRNA code offer new opportunities in both rare genetic diseases and common complex ones.
-
Development and validation of a new algorithm for improved cardiovascular risk prediction Nat. Med. (IF 82.9) Pub Date : 2024-04-18 Julia Hippisley-Cox, Carol A. C. Coupland, Mona Bafadhel, Richard E. K. Russell, Aziz Sheikh, Peter Brindle, Keith M. Channon
-
Targeting KRAS in cancer Nat. Med. (IF 82.9) Pub Date : 2024-04-18 Anupriya Singhal, Bob T. Li, Eileen M. O’Reilly
-
An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial Nat. Med. (IF 82.9) Pub Date : 2024-04-18 Amit Saraf, Rohan Gurjar, Swarnendu Kaviraj, Aishwarya Kulkarni, Durgesh Kumar, Ruta Kulkarni, Rashmi Virkar, Jayashri Krishnan, Anjali Yadav, Ekta Baranwal, Ajay Singh, Arjun Raghuwanshi, Praveen Agarwal, Laxman Savergave, Sanjay Singh
-
Discovery of a Potent Dual Son of Sevenless 1 (SOS1) and Epidermal Growth Factor Receptor (EGFR) Inhibitor for the Treatment of Prostate Cancer J. Med. Chem. (IF 7.3) Pub Date : 2024-04-17 Lufeng Zheng, Yuxin Zhang, Shuang Mei, Tianyuan Xie, Yunting Zou, Yuting Wang, Han Jing, Shengtao Xu, Pierre Dramou, Zhen Xu, Jindong Li, Yang Zhou, Miao-Miao Niu
-
Benzothiazole derivatives as histone deacetylase inhibitors for the treatment of autosomal dominant polycystic kidney disease Eur. J. Med. Chem. (IF 6.7) Pub Date : 2024-04-18 Xudong Cao, Zhiyuan Fan, Lingfang Xu, Wenchao Zhao, Haoran Zhang, Yunfang Yang, Ying Ren, Yuxian Xiao, Nan Zhou, Long Yin, Xueyan Zhou, Xu Zhu, Dong Guo
-
Design, synthesis, and biological evaluation of 3-phenyl substituted pyridine derivatives as potential dual inhibitors of XOR and URAT1 Eur. J. Med. Chem. (IF 6.7) Pub Date : 2024-04-18 Chao Yang, Haojie Cai, Xinying Zhu, Lei Zhang, Jing Li
-
Structural Elucidation and Antiviral Activity of Covalent Cathepsin L Inhibitors J. Med. Chem. (IF 7.3) Pub Date : 2024-04-17 Sven Falke, Julia Lieske, Alexander Herrmann, Jure Loboda, Katarina Karničar, Sebastian Günther, Patrick Y. A. Reinke, Wiebke Ewert, Aleksandra Usenik, Nataša Lindič, Andreja Sekirnik, Klemen Dretnik, Hideaki Tsuge, Vito Turk, Henry N. Chapman, Winfried Hinrichs, Gregor Ebert, Dušan Turk, Alke Meents
-
Design, Synthesis, and Biological Evaluation of β-Trifluoroethoxydimethyl Selenides as Potent Antiosteoporosis Agents J. Med. Chem. (IF 7.3) Pub Date : 2024-04-17 Yao Wu, Bin Li, Linkun Ying, Yao Chen, Yuxin Zhang, Chaoming Hu, Yichi Zhang, Lele Yi, Weiwei Xue, Shengbin Huang, Zengqiang Song
-
Three-step cures for autoimmune diseases? Nat. Rev. Drug. Disc. (IF 120.1) Pub Date : 2024-04-17
Robert Plenge, head of Research at Bristol Myers Squibb, discusses his vision of sequential immunotherapy for autoimmune diseases — including multiple sclerosis.
-
The fasciola cinereum of the hippocampal tail as an interventional target in epilepsy Nat. Med. (IF 82.9) Pub Date : 2024-04-17 Ryan M. Jamiolkowski, Quynh-Anh Nguyen, Jordan S. Farrell, Ryan J. McGinn, David A. Hartmann, Jeff J. Nirschl, Mateo I. Sanchez, Vivek P. Buch, Ivan Soltesz
-
Nicotine e-cigarettes: considerations for healthcare providers Nat. Med. (IF 82.9) Pub Date : 2024-04-16 Benjamin A. Toll, Tracy T. Smith, Brian A. King
Tobacco use continues to be the leading cause of preventable disease and death in the United States. There are no safe tobacco products; however, the health risks for tobacco products exist on a continuum, with combustible products such as cigarettes being the most harmful. Decades of research have documented that cigarette smoking harms nearly every organ of the body; cigarette smoke contains nearly
-
A framework for implementing patient-reported outcomes in clinical care: the PROTEUS-practice guide Nat. Med. (IF 82.9) Pub Date : 2024-04-16 Norah L. Crossnohere, Nicola Anderson, Judith Baumhauer, Melanie Calvert, Rebecca Esparza, Sandi Gulbransen, Lotte Haverman, Yuchen Li, Carolyn Petersen, Ameeta Retzer, Christopher Sidey-Gibbons, Angela M. Stover, Elissa Thorner, Garrett Ursin, Galina Velikova, Elliott Sparkman Walker, Michael Brundage, Claire Snyder
-
Placental IGFBP1 levels during early pregnancy and the risk of insulin resistance and gestational diabetes Nat. Med. (IF 82.9) Pub Date : 2024-04-16 Marie-France Hivert, Frédérique White, Catherine Allard, Kaitlyn James, Sana Majid, François Aguet, Kristin G. Ardlie, Jose C. Florez, Andrea G. Edlow, Luigi Bouchard, Pierre-Étienne Jacques, S. Ananth Karumanchi, Camille E. Powe
-
Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning Nat. Med. (IF 82.9) Pub Date : 2024-04-16 Fei Tian, Dong Liu, Na Wei, Qianqian Fu, Lin Sun, Wei Liu, Xiaolong Sui, Kathryn Tian, Genevieve Nemeth, Jingyu Feng, Jingjing Xu, Lin Xiao, Junya Han, Jingjie Fu, Yinhua Shi, Yichen Yang, Jia Liu, Chunhong Hu, Bin Feng, Yan Sun, Yunjun Wang, Guohua Yu, Dalu Kong, Meiyun Wang, Wencai Li, Kexin Chen, Xiangchun Li
-
Transparent medical image AI via an image–text foundation model grounded in medical literature Nat. Med. (IF 82.9) Pub Date : 2024-04-16 Chanwoo Kim, Soham U. Gadgil, Alex J. DeGrave, Jesutofunmi A. Omiye, Zhuo Ran Cai, Roxana Daneshjou, Su-In Lee
-
Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s disease Nat. Med. (IF 82.9) Pub Date : 2024-04-15 Gennaro Pagano, Kirsten I. Taylor, Judith Anzures Cabrera, Tanya Simuni, Kenneth Marek, Ronald B. Postuma, Nicola Pavese, Fabrizio Stocchi, Kathrin Brockmann, Hanno Svoboda, Dylan Trundell, Annabelle Monnet, Rachelle Doody, Paulo Fontoura, Geoffrey A. Kerchner, Patrik Brundin, Tania Nikolcheva, Azad Bonni
-
Synthesis and Structure–Activity Relationships for Glutamate Transporter Allosteric Modulators J. Med. Chem. (IF 7.3) Pub Date : 2024-04-16 Andréia C. K. Fontana, Adi N.R. Poli, Jitendra Gour, Yellamelli V.V. Srikanth, Nicholas Anastasi, Devipriya Ashok, Apeksha Khatiwada, Katelyn L. Reeb, Mary Hongying Cheng, Ivet Bahar, Scott M. Rawls, Joseph M. Salvino